US Direct Anterior Approach Market Size was valued at USD 0.9 Billion in 2023. The direct anterior approach market industry is projected to grow from USD 1.02 Billion in 2024 to USD 2.52 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.94% during the forecast period (2024 - 2032). The expansion can be seen as a result of beneficial reimbursement policies, an increase in arthritis sufferers, and technological developments in this area. The government's initiative to allocate more funds and create new policies has also decreased the wait time for hip reconstructions and boosted the number of procedures. These market drivers have the potential to significantly fuel market expansion. The need for and cost of revision surgery are reduced by technological breakthroughs like newly created prostheses with stronger and more reliable joints.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
One of the main causes of geriatric hip discomfort being worsened is osteoarthritis. The rise in the number of senior persons is another factor whose positive impact on the market is projected. There are already almost 42.6 million Americans over 65, and by 2030, that number is anticipated to considerably rise. The direct anterior approach (DAA) is a minimally invasive surgical treatment that involves only a small incision and no tendon-cutting. This method has the advantages of short operation times, minimal postoperative discomfort, and speedy patient recovery. Thus, the prevalence of disorders of the lower extremities such osteoarthritis (OA) and osteoporosis, as well as hip and osteoporosis issues, are all contributing reasons to the market CAGR. Furthermore, it is simpler to support market expansion because industrialized countries have access to developing healthcare infrastructure and improvements in minimally invasive surgery technology. 130 million individuals will suffer osteoarthritis by 2050, according to a report by the Osteoarthritis Research Society International.
Enhance advantages and benefits with technological breakthroughs in the orthopedics sectors and include more technologies, which will spur market expansion and consumer demand in response to expanding government reimbursement programmes and rising medical industry investment. As a result, the market will grow as more people have access to new technology and can benefit from it. Leading market players actively participate in the introduction of new products and carry out ongoing research to find new products with improved performance that will expand the direct anterior's customer base. During the projection period, the top market players will invest more money in new surgical advancements and market expansion.
3D printing technology is a new key advance in the field that is being used more commonly in direct anterior approach. The invention is used to create guidelines for each patient that are customized to their needs in order to align the implants properly and in accordance with the initial design. This is known as patient-specific instrumentation. Using a CT scan, this technique customizes a preoperative plan for each patient's anatomy. It aids the operating doctor in accurately planning and carrying out the acetabular implant placement while preserving hip stability. The development of computer assistance and automation has made it possible to reduce human error, improve implant placement accuracy, and restore natural hip mechanics. Thus, driving the direct anterior approach market revenue.
The US Direct Anterior Approach market segmentation, based on type includes S. Total Hip Replacement by DAA and S. Total Hip Replacement Market for DAA by ASC. The S. total hip replacement by DAA segment dominated the market because there is less scarring after this type of surgery, the healing period is shorter, and the hospital stay is shorter.
Figure 1 US Direct Anterior Approach Market, by Type, 2023 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
The U.S. direct anterior approach (total hip replacement) in ACS market has been expanding as a result of the rising demand for minimally invasive procedures. The advantages of minimally invasive surgery could fuel market growth in the US during the course of the forecast. In order to strengthen their market position, large producers are also focusing on technological developments and expanding their geographic reach. Furthermore, the market in the United States has expanded as a result of these companies' use of continual innovation as a competitive advantage. Increased injury rates and rising obesity rates may also encourage market growth. The region's market has benefited greatly from the presence of a top-notch healthcare system. Key producers are launching new products to keep the market afloat.
US Direct Anterior Approach Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the direct anterior approach market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, direct anterior approach industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the US Direct Anterior Approach industry to benefit clients and increase the market sector. In recent years, the direct anterior approach industry has offered some of the most significant advantages to market. Major players in the direct anterior approach market attempting to increase market demand by investing in research and development operations include Smith & Nephew, Proliance Surgeons, OrthAlign Inc., Bone & Joint Surgery Clinic, Center for Special Surgery, Stryker Corporation, Orthoillinois, Zimmer Biomet, Johnson & Johnson Services Inc. (DePuy Synthes) and The Hip and Knee Center.
ENT, sports medicine, advanced wound treatment, orthopedic reconstruction, and trauma are among the fields in which Smith & Nephew Plc develops, produces, and markets medical devices. The business provides hip and knee implants to replace worn, sick, or injured joints, robotics-assisted technologies, and trauma-related goods to stabilize fractures and repair deformities. Additionally, it provides products for treating wounds and equipment for removing and repairing soft tissue. Surgeons, nurses, nurse practitioners, doctors, general practitioners, purchasing staff in hospitals, and health insurers are just a few of the people Smith & Nephew sells its goods to.
Healthcare for the musculoskeletal system is the primary business focus of Zimmer Biomet Holdings Inc. The business creates, manufactures, and sells orthopedic reconstructive products, biologics, sports medicine, extremities, and trauma products, as well as a variety of integrated digital and robotic solutions for the thorax and the craniomaxillofacial region, office-based technologies, and related surgical items. Its goods and services help treat patients with conditions or wounds to the bones, joints, and supporting soft tissues. Hospitals, healthcare dealers, orthopedic surgeons, neurosurgeons, other specialists, stocking distributors, and healthcare purchasing organisations are among the markets that Zimmer Biomet serves with its goods.
Key Companies in the US direct anterior approach market include
High Pressure Seals Industry Developments
June 2018 HipGrid NINE, developed by OrthoGrid equipment for outpatient total hip replacement, increases the usefulness of C-arm imaging equipment, which are frequently seen in hospitals and ambulatory surgery centers.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 0.9 Billion |
| Market Size 2024 | USD 1.02 Billion |
| Market Size 2032 | USD 2.52 Billion |
| Compound Annual Growth Rate (CAGR) | 11.94% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type and Region |
| Countries Covered | The US |
| Key Companies Profiled | Smith & Nephew, Proliance Surgeons, OrthAlign Inc., Bone & Joint Surgery Clinic, Center for Special Surgery, Stryker Corporation, Orthoillinois, Zimmer Biomet, Johnson & Johnson Services Inc. (DePuy Synthes) and The Hip and Knee Center |
| Key Market Opportunities | The high demand for hip reconstruction products |
| Key Market Dynamics | Increasing demand for minimally invasive surgery |
U.S. Direct Anterior Approach Market Highlights:
Frequently Asked Questions (FAQ) :
The US Direct Anterior Approach market size was valued at USD 0.9 Billion in 2023.
The market is projected to grow at a CAGR of 11.94% during the forecast period, 2024-2032.
The key players in the market are Smith & Nephew, Proliance Surgeons, OrthAlign Inc., Bone & Joint Surgery Clinic, Center for Special Surgery, Stryker Corporation, Orthoillinois, Zimmer Biomet, Johnson & Johnson Services Inc. (DePuy Synthes) and The Hip and Knee Center.
The S. Total Hip Replacement by DAA category dominated the market in 2022.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
